Advocacy

Lung Cancers Today
The Power of Community: Jill Feldman Shares Advice for Getting Involved in Lung Cancer Advocacy Advocacy

The Power of Community: Jill Feldman Shares Advice for Getting Involved in Lung Cancer Advocacy

*November 2025* Jill Feldman, a patient advocate with lung cancer and co-founder of the EGFR Resisters, joined Lung Cancers Today to discuss her journey into lung cancer advocacy, provide advice for those who are interested in getting involved, and reflect on the power of finding community. Watch the video here and read the…
laurabbook@gmail.com
June 25, 2026
IASLC
The New Face of Lung Cancer: A Conversation with Two Young Lung Cancer Warriors AdvocacyCoping With Cancer

The New Face of Lung Cancer: A Conversation with Two Young Lung Cancer Warriors

*November 2025* In this episode of Lung Cancer Considered, host Dr. Narjust Florez speaks with two remarkable young lung cancer advocates Samantha Murell and Megan Flanagan, who are redefining what it means to live with the disease. They share their journeys from diagnosis to advocacy, shedding light on the challenges…
laurabbook@gmail.com
June 25, 2026
Inaugural EGFR Resisters Patient and Caregiver Summit Was Awesome! AdvocacyResearchTreatments

Inaugural EGFR Resisters Patient and Caregiver Summit Was Awesome!

*November 2025* At its heart, a community is defined by what brings people together, no matter how different our lives or experiences. And few things unite us more than a shared purpose and shared hope. This past November, more than 110 patients and caregivers impacted by EGFR‑positive lung cancer gathered…
laurabbook@gmail.com
June 24, 2026
Oncology News Central
“Milestone” in EGFR-Positive NSCLC: The Importance of Options for Patient-Centered Care AdvocacyResearchTreatments

“Milestone” in EGFR-Positive NSCLC: The Importance of Options for Patient-Centered Care

*September 2025* In this episode of LungCancerRx, the experts talk about the FLAURA2 and HARMONi data presented at the World Conference on Lung Cancer and what the findings mean for patients with EGFR-mutated non-small cell lung cancer (NSCLC). Recorded onsite in Barcelona, Spain, cohost Eric Singhi, MD, from Houston, Texas, is…
laurabbook@gmail.com
March 26, 2026
IASLC
How to Read & Write Conference Abstracts AdvocacyResearch

How to Read & Write Conference Abstracts

*August 2025* This webinar focuses on helping patient research advocates understand and engage with conference abstracts, covering topics from abstract structure and critical evaluation to writing impactful abstracts. Presenters including Andrew, Anne-Marie, Upal, Jill, and Lillian provided guidance on various aspects of abstracts, from their purpose and structure to reviewing…
laurabbook@gmail.com
March 26, 2026
Bonnie Addario
AdvocacyStories

Tribute to Bonnie Addario

Written by Colleen Sturdivant Many in this community are likely familiar with Bonnie Addario and her positive impact on the lung cancer community. But many of you may not know that Bonnie was an early supporter of the EFGR Resisters. I became aware of the Bonnie J. Addario Lung Cancer…
laurabbook@gmail.com
March 24, 2026
BBC logo
Advocacy

The mystery rise of lung cancer in non-smokers

*June 2025* The number of lung cancer cases in people who have never smoked is increasing. The disease is different from lung cancer caused by smoking, so what causes it? Martha first realised that something was wrong when her cough changed and the mucus in her airways became increasingly viscous.…
laurabbook@gmail.com
November 21, 2025
Oncology News Central
Advocacy

Empowered Choices: “The Most Important Conversations” Oncologists Can Have With NSCLC Patients

*July 2025* When it comes to treatment decisions for patients with EGFR-mutated non-small cell lung cancer, “the most important conversations are not the data-driven ones, they are the relational ones,” says patient advocate Jill Feldman. In the second episode of the LungCancerRx video podcast, cohosts Fawzi F. Abu Rous, MD, a thoracic medical oncologist…
laurabbook@gmail.com
November 20, 2025